Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

ClinicalTrials.gov ID: NCT01756898

Public ClinicalTrials.gov record NCT01756898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research study is to gather scientific information about the effectiveness of the study drug, ASB17061 capsules, when compared to placebo in adult subjects with atopic dermatitis.

Study identification

NCT ID
NCT01756898
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
370 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 28, 2012 (Actual)
Primary completion
Jan 14, 2014 (Actual)
Completion
Jan 14, 2014 (Actual)
Last update posted
Feb 16, 2021

2012 – 2014

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
38
Facility City State ZIP Site status
Not listed Birmingham Alabama 35233 —
Not listed Phoenix Arizona 85018 —
Not listed Rogers Arkansas 72758 —
Not listed Encino California 91436 —
Not listed Fremont California 94538 —
Not listed San Diego California 92122 —
Not listed Temecula California 92592 —
Not listed Denver Colorado 80220 —
Not listed Miami Florida 33144 —
Not listed Miami Florida 33175 —
Not listed Miramar Florida 33027 —
Not listed Saint Augustine Florida 32086 —
Not listed South Tampa Florida 33609 —
Not listed Tampa Florida 33609 —
Not listed Tampa Florida 33613 —
Not listed Savannah Georgia 31405 —
Not listed Boise Idaho 83704 —
Not listed Overland Park Kansas 66215 —
Not listed Crowley Louisiana 70526 —
Not listed Bay City Michigan 48706 —
Not listed Clinton Township Michigan 48038 —
Not listed Fort Gratiot Michigan 48059 —
Not listed Berlin New Jersey 08009 —
Not listed Verona New Jersey 07044 —
Not listed Stony Brook New York 11790 —
Not listed Raleigh North Carolina 27612 —
Not listed Sylvania Ohio 43560 —
Not listed Lake Oswego Oregon 97035 —
Not listed Portland Oregon 97239 —
Not listed Johnston Rhode Island 02919 —
Not listed Arlington Texas 76011 —
Not listed College Station Texas 77845 —
Not listed Pflugerville Texas 78660 —
Not listed San Antonio Texas 78229 —
Not listed Webster Texas 77598 —
Not listed Draper Utah 84020 —
Not listed West Jordan Utah 84088 —
Not listed Henrico Virginia 23233 —
Not listed Norfolk Virginia 23507 —
Not listed Spokane Washington 99204-4880 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01756898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 16, 2021 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01756898 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →